Spots on skin
|
phenotype |
Skin and Connective Tissue Diseases
|
Sign or Symptom
|
43
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Primary cholangiocarcinoma of intrahepatic biliary tract
|
disease |
Neoplasms
|
Neoplastic Process
|
274
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adult Langerhans Cell Histiocytosis
|
disease |
Respiratory Tract Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
40
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Childhood Langerhans Cell Histiocytosis
|
disease |
Respiratory Tract Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
40
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
CONE DYSTROPHY, X-LINKED, 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Thyroid Neoplasm
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1164
|
135
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Noonan Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
85
|
187
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mycoses
|
group |
Infections
|
Disease or Syndrome
|
94
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lichen disease
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Histiocytosis, Non-Langerhans-Cell
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Histiocytosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
3
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
949
|
103
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Tuberculosis
|
disease |
Infections
|
Disease or Syndrome
|
1256
|
328
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Buruli Ulcer
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
13
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Fibrolamellar Hepatocellular Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
46
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
10
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |